Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against UnitedHealth Group Incorporated (UNH)

Core Viewpoint - The article discusses a class action lawsuit against UnitedHealth Group Incorporated, highlighting an investigation by the U.S. Department of Justice into the company's operations and the implications for investors [2][3]. Group 1: Class Action Details - Investors have until July 15, 2024, to file a lead plaintiff motion in the class action for those who purchased UnitedHealth stock between March 14, 2022, and February 27, 2024 [1][4]. - The lawsuit alleges that UnitedHealth made materially false and misleading statements regarding its business practices and failed to disclose significant adverse facts [3]. Group 2: Investigation and Stock Impact - On February 27, 2024, it was reported that the DOJ is investigating the relationship between UnitedHealthcare and Optum, leading to a significant drop in UnitedHealth's stock price by $27.04, or 5.1%, closing at $498.28 per share on February 28, 2024 [2]. - The investigation centers on the lack of proper firewalls between the two units, which were supposed to protect sensitive customer information [3].